Skip to main content
Scienture Holdings, Inc. logo

Scienture Holdings, Inc. — Investor Relations & Filings

Ticker · SCNX ISIN · US89846A2078 US Manufacturing
Filings indexed 495 across all filing types
Latest filing 2014-09-12 Regulatory Filings
Country US United States of America
Listing US SCNX

About Scienture Holdings, Inc.

https://www.trxadehealth.com/

Scienture Holdings, Inc. is a holding company that operates through its subsidiaries, including Scienture, LLC and Integra Pharma Solutions, LLC. The company functions as an integrated pharmaceutical and health services provider focused on the development, commercialization, and distribution of novel specialty products. A key therapeutic area includes treatments for central nervous system disorders. Scienture Holdings aims to enhance value for patients and physicians by addressing the needs of underserved populations and bridging gaps in treatment delivery systems to improve healthcare outcomes. The company also provides a web-based purchasing platform for transactions.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2014
Regulatory Filings
2014-09-12 English
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a letter from the company to the SEC responding to comments on an Amendment No. 2 to a Registration Statement on Form 10. It addresses specific SEC staff comments, clarifies disclosures, and mentions filing an Amendment No. 3 concurrently. The document is a correspondence related to regulatory review and filing amendments, not a financial report or earnings release. It is short (3826 characters) and serves as a regulatory response letter rather than a report itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory correspondence and filings that do not fit other categories.
2014-09-05 English
FORM 10/A3
Regulatory Filings Classification · 95% confidence The document is titled 'Amendment No. 3 to FORM 10' and is a SEC filing under the Securities Exchange Act of 1934, specifically a Form 10 registration statement. It contains detailed business descriptions, corporate history, risk factors, financial information, and other comprehensive disclosures typical of a registration statement. It is not an annual report (10-K), quarterly report (10-Q), or earnings release. The Form 10 is a general form for registration of securities and is a regulatory filing. Given the detailed nature and the form type, this document fits best under Regulatory Filings (RNS) as it is a registration statement amendment and does not match other more specific categories like Annual Report or Capital/Financing Update. The document length is substantial and contains substantive content, not just an announcement or certification, so it is not RPA or a certification filing.
2014-09-05 English
Regulatory Filings 2014
Regulatory Filings
2014-08-26 English
Regulatory Filings 2014
Regulatory Filings
2014-08-26 English
Regulatory Filings 2014
Regulatory Filings
2014-08-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.